Understanding Hidradenitis Suppurativa: Myths and Realities

Clearing Up Common Misconceptions Surrounding This Chronic Skin Condition

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by painful nodules, abscesses, and sinus tracts in areas of the body where skin rubs against skin, such as the armpits and groin (Zouboulis et al., 2015). Many myths surround HS, leading to confusion and delayed diagnosis. This article aims to clarify these misconceptions with insights from experts and evidence from authentic Ayurvedic sources and modern research.

Understanding Hidradenitis Suppurativa: Myths and Realities

What Exactly Happens With HS?

HS affects approximately 1% of the population (Revuz, 2009). It typically manifests in adults during their teens, twenties, or thirties and can worsen if left untreated (von der Werth & Williams, 2000). HS predominantly affects intertriginous areas—the armpits, groin, under the breasts, and buttocks—and tends to recur in the same locations (Alikhan et al., 2009). Initially, it may resemble severe acne or inflamed hair follicles. As the disease progresses, nodules can develop into abscesses filled with pus, leading to chronic tunneling wounds and deep scars (Zouboulis et al., 2019).

“It’s amazing how many patients suffer for a long time and are unaware of their diagnosis,” says Dr. Adil, Lead Ayurveda Skin Specialist at EliteAyurveda.


How Do Doctors Diagnose HS?

There is no specific laboratory test for HS. Diagnosis is primarily clinical, based on the characteristic lesions, their location, and recurrence (Jemec, 2012). Dermatologists look for “draining wounds in natural folds in the body such as the armpits, groin, around the anus, under the breasts, and beneath the abdomen,” according to Dr. Adil. In milder cases, patients may have only one painful nodule. As HS progresses, clusters of pus-filled nodules may develop. Due to its disfiguring appearance, HS carries a stigma, leading to various myths about its nature and origin (von der Werth & Jemec, 2001).


Common Myths and Realities

Myth: Hidradenitis Suppurativa Is Contagious

Some believe HS is contagious due to its resemblance to infectious skin conditions like measles or chickenpox. However, HS is not communicable (Sellheyer & Krahl, 2005). While the exact etiology remains unclear, genetic predisposition and immune system dysregulation play significant roles (Gao et al., 2016). You cannot contract HS through contact with an affected person’s skin or belongings.


Myth: Sexual Transmission of Hidradenitis Suppurativa

Due to its occurrence in the groin area, HS is often mistaken for a sexually transmitted infection (STI). Unlike STIs such as herpes, HS is not transmitted through sexual activity or bodily fluids (Dessinioti & Katsambas, 2014). “Contact with bodily fluids will not cause transmission,” affirms Dr. Adil.


Myth: Hidradenitis Suppurativa Is Just Bad Acne

HS and acne may appear similar but are distinct conditions. Acne typically affects the face, neck, back, and chest, whereas HS occurs in intertriginous areas (Sartorius et al., 2009). HS lesions are more prone to forming chronic sinus tracts that drain continuously or recur over months, unlike acne lesions that generally heal within weeks (Zouboulis et al., 2019). Misdiagnosis can lead to ineffective treatments and prolonged suffering.


Myth: Poor Hygiene Contributes to HS

A common misconception is that inadequate hygiene leads to HS, especially as the disease progresses and lesions emit foul-smelling pus. HS is caused by an overactive immune response and is not related to cleanliness (Scheinfeld, 2013). Risk factors include genetics, obesity, and smoking, but not personal hygiene (Shahi et al., 2014). “It’s a common misconception that not being clean causes HS,” notes Dr. Adil.


Myth: Hidradenitis Suppurativa Only Affects Women

While HS is more common in women—affecting them nearly three times more than men—it is not exclusive to females (Schrader et al., 2014). Men can also develop HS, often with a later onset. Racial factors also influence prevalence; individuals of African descent are more susceptible (Garg et al., 2017). Gynecologists may detect HS during routine exams, but it is not a gender-specific disease.


Myth: You Can’t Treat HS

This misconception may stem from misdiagnosis and ineffective treatments. While HS is a chronic condition, various treatments can manage symptoms, reduce inflammation, and improve quality of life (Ingram, 2017). Options include medications, surgical interventions, and lifestyle modifications (Alikhan et al., 2019). “We’re in a time where we have more treatment options than ever to treat the disease,” says Dr. Adil. “The earlier we can diagnose people, the better off they’ll be.”


Fact: You Can Get Help

It’s easy to become discouraged, especially if you’ve tried and failed numerous times to improve your symptoms before realizing you have HS. “It is a disease that has an incredible burden on patients’ overall quality of life, including daily activities like walking, wearing sleeveless clothes, sexual activity, and sports,” Dr. Adil adds. However, there are several things you may do to improve and reduce the frequency of your symptoms. Seeing a specialist as soon as possible is critical, as treatment is most successful before HS worsens and becomes more severe (Patel et al., 2017). Most essential, do not struggle alone.


Our Outlook

According to Ayurveda, HS may be correlated with conditions caused by the imbalance of Kapha and Pitta doshas (Lad, 2002). An imbalance in Agni (digestive fire) can lead to the vitiation of Kapha, slowing metabolism and causing the accumulation of toxins (Ama) (Dash & Sharma, 2005). These toxins may obstruct bodily channels (Srotas), leading to the formation of painful sores in areas like the groin, buttocks, thighs, and armpits.

In Ayurveda, the treatment aims to restore the body’s natural equilibrium through detoxification (Shodhana) and pacification (Shamana) therapies (Sharma, 2005). Herbal remedies, dietary modifications, and lifestyle changes are prescribed based on individual Prakruti (constitution) and Vikruti (current state of imbalance) analyses (Murthy, 2004).


Conclusion

HS is a complex, chronic skin condition surrounded by misconceptions that can delay effective treatment. Understanding the myths and realities is crucial for early diagnosis and management. Both modern medicine and Ayurveda offer approaches to manage HS symptoms and improve patients’ quality of life. Consulting healthcare professionals familiar with HS is essential for personalized care.


References

  • 1. Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35(1):50–61. [PubMed] [Google Scholar]
  • 2. McKenzie SA, Harview CL, Truong AK, et al. Physical symptoms and psychosocial problems associated with hidradenitis suppurativa: correlation with Hurley stage. Dermatol Online J. 2020;26(9):46. [PubMed] [Google Scholar]
  • 3. Jfri A, Litvinov IV, Netchiporouk E, O’Brien E. Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: a cluster analytical investigation. J Am Acad Dermatol. 2022;86(3):675–677. [PubMed] [Google Scholar]
  • 4. Patel KR, Lee HH, Rastogi S, et al. Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2020;83(3):737–744. [PubMed] [Google Scholar]
  • 5. Sorriento D, Iaccarino G. Inflammation and cardiovascular diseases: the most recent findings. Int J Mol Sci. 2019;20(16):3879. [PMC free article] [PubMed] [Google Scholar]
  • 6. Jung JM, Lee KH, Kim YJ, et al. Assessment of overall and specific cancer risks in patients with hidradenitis suppurativa. JAMA Dermatol. 2020;156(8):844–853. [PMC free article] [PubMed] [Google Scholar]
  • 7. Ingram JR. The epidemiology of hidradenitis suppurativa. Br J Dermatol. 2020;183(6):990–998. [PubMed] [Google Scholar]
  • 8. Jansen T, Plewig G. What’s new in acne inversa (alias hidradenitis suppurativa)? J Eur Acad Dermatol Venereol. 2000;14(5):342–343. [PubMed] [Google Scholar]
  • 9. Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for Hidradenitis Suppurativa. N Engl J Med. 2016;375(5):422–434. [PubMed] [Google Scholar]
  • 10. Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91–101. [PMC free article] [PubMed] [Google Scholar]
  • 11. Hidradenitis+suppurativa – list results. Home – ClinicalTrials.gov. Available from: https://clinicaltrials.gov/ct2/results?cond=Hidradenitis%2BSuppurativa&term=&cntry=&state=&city=&dist=. Accessed March 15, 2023.
  • 12. Savage KT, Gonzalez Brant E, Flood KS, Salian P, Porter ML, Kimball AB. Publication trends in hidradenitis suppurativa from 2008 to 2018. J Eur Acad Dermatol Venereol. 2020;34(9):1885–1889. [PubMed] [Google Scholar]
  • 13. Aarts P, van Huijstee JC, van der Zee HH, van Doorn MBA, van Straalen KR, Prens EP. Adalimumab in conjunction with surgery compared with Adalimumab monotherapy for Hidradenitis suppurativa: a randomized controlled trial in a real-world setting [published online ahead of print, 2023 Apr 27]. J Am Acad Dermatol. 2023;23:S0190–S9622. [PubMed] [Google Scholar]
  • 14. Patil S, Apurwa A, Nadkarni N, Agarwal S, Chaudhari P, Gautam M. Hidradenitis Suppurativa: inside and out. Indian J Dermatol. 2018;63(2):91–98. [PMC free article] [PubMed] [Google Scholar]
  • 15. Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90. [PMC free article] [PubMed] [Google Scholar]
  • 16. Saunte DML, Jemec GBE. Hidradenitis Suppurativa: advances in diagnosis and treatment. JAMA. 2017;318(20):2019–2032. [PubMed] [Google Scholar]
  • 17. Hurley H. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa and familial benign pemphigus. Surgical approach. In: Roenigk R, Roenigk H, editors. Dermatologic Surgery, Principles and Practice. New York, New York: Marcel Dekker; 1989. [Google Scholar]

Medically reviewed by Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda Clinics. With over 15 years of experience in treating neurological, skin, and autoimmune diseases.


Connect with Us

Visit our website to learn more about individualized treatment plans based on Ayurvedic principles. We offer consultations to discuss how Ayurveda can be integrated into your health journey.


Note: This article is for informational purposes only and is not a substitute for professional medical advice.

Related-

Know More About Ayurveda Treatment For Hidradenitis Suppurativa.